Have a personal or library account? Click to login
Complete Response of a Patient with Squamous Cell Carcinoma of the Sigmoid Colon: A Case Report Cover

Complete Response of a Patient with Squamous Cell Carcinoma of the Sigmoid Colon: A Case Report

Open Access
|Mar 2025

Abstract

Background

Squamous cell carcinoma of the sigmoid colon is an exceedingly rare and often late-diagnosed form of colon cancer. It presents diagnostic and therapeutic challenges due to its rarity and nonspecific symptoms. This case report aims to enhance understanding and awareness of this uncommon malignancy.

Case Presentation

We present the case of a 59-year-old female with advanced stage squamous cell carcinoma of the sigmoid colon, accompanied by metastases to regional lymph nodes, peritoneum, and omentum. Initial imaging and colonoscopy confirmed the diagnosis, and due to the absence of established treatment guidelines, a unique chemotherapy regimen combining paclitaxel, carboplatin, and bevacizumab was initiated. Remarkably, the patient exhibited a significant improvement in performance status and achieved complete remission following 16 weeks of treatment.

Conclusion

This case highlights the diagnostic challenges and therapeutic complexities associated with squamous cell carcinoma of the sigmoid colon. The exceptional response to tailored chemotherapy underscores the importance of individualized treatment approaches in rare malignancies. Further research and clinical trials are warranted to establish effective therapeutic strategies and improve patient outcomes in similar cases.

DOI: https://doi.org/10.2478/fco-2023-0043 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 90 - 96
Submitted on: Apr 28, 2024
|
Accepted on: Oct 12, 2024
|
Published on: Mar 8, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Yaala Saady Raof Al-Bairmany, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.